Chemours shares jumped 6.1% to close at $21.17 after the company reached a comprehensive settlement with the U.S. EPA to resolve PFAS-related claims, reducing a significant regulatory overhang. The move was backed by solid volume and follows a 9.7% decline over the prior four weeks. Investors also reacted positively to the structured payment schedule, the resolution of additional litigation in West Virginia, and continued progress under the company's strategy to address legacy environmental liabilities. The company is expected to report quarterly earnings of $0.39 per share on revenues of $1.65 billion. Zacks Investment Research currently rates Chemours a Hold.
Chemours CoPFAS settlement with EPA reduces regulatory overhang
Avient Corp